Your browser doesn't support javascript.
loading
Four Weeks Treatment with Glecaprevir/Pibrentasvir + Ribavirin-A Randomized Controlled Clinical Trial.
Madsen, Lone W; Christensen, Peer B; Hansen, Janne F; Røge, Birgit T; Holm, Dorte K; Dröse, Sandra; Øvrehus, Anne.
Affiliation
  • Madsen LW; Department of Infectious Diseases, Odense University Hospital, 5000 Odense, Denmark.
  • Christensen PB; OPEN, Odense Patient Data Explorative Network, Odense University Hospital, 5000 Odense, Denmark.
  • Hansen JF; Clinical Institute, University of Southern Denmark, 5000 Odense, Denmark.
  • Røge BT; Department of Infectious Diseases, Odense University Hospital, 5000 Odense, Denmark.
  • Holm DK; Clinical Institute, University of Southern Denmark, 5000 Odense, Denmark.
  • Dröse S; Department of Infectious Diseases, Odense University Hospital, 5000 Odense, Denmark.
  • Øvrehus A; Unit for Infectious Diseases, Department of Medicine, Sygehus Lillebælt, 6000 Kolding, Denmark.
Viruses ; 14(3)2022 03 16.
Article in En | MEDLINE | ID: mdl-35337021
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis C, Chronic / COVID-19 Type of study: Clinical_trials Limits: Humans Language: En Journal: Viruses Year: 2022 Document type: Article Affiliation country: Dinamarca Country of publication: Suiza
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hepatitis C, Chronic / COVID-19 Type of study: Clinical_trials Limits: Humans Language: En Journal: Viruses Year: 2022 Document type: Article Affiliation country: Dinamarca Country of publication: Suiza